August 30, 2014 11:20 PM ET

Pharmaceuticals

Company Overview of Cellective Therapeutics, Inc.

Company Overview

As of October 14, 2005, Cellective Therapeutics, Inc. was acquired by MedImmune, LLC. Cellective Therapeutics, Inc., a drug development company, engages in discovering, developing, and commercializing monoclonal antibodies for the treatment of B-cell cancers and autoimmune diseases. Its products include monoclonal antibodies that target the B-cell antigens CD19, CD20, and CD22 are in preclinical stage programs. The company was founded in 2003 and is based in Gaithersburg, Maryland. It also has offices in North Carolina and Maryland.

35 West Watkins Mill Road

Suite 100

Gaithersburg, MD 20878

United States

Founded in 2003

Phone:

301-977-7042

Fax:

301-977-7215

Key Executives for Cellective Therapeutics, Inc.

Cellective Therapeutics, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Albion Medical Holdings, Inc. United States
Neurion Pharmaceuticals, Inc. United States
Plymouth Pharmaceuticals, Inc. United States
Powder Processors, Inc. United States
Zand Herbal Formulas United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Cellective Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.